Other
Havenziekenhuis
Total Trials
6
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed trials have results
Key Signals
1 with results
Enrollment Performance
Analytics
N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT03138096Phase 1Completed
Safety and Protective Efficacy of Pb(PfCS@UIS4)
Role: collaborator
NCT02166112Completed
The Permacol Dutch Cohort Study
Role: collaborator
NCT02149550Not ApplicableCompleted
Controlled Human Malaria Infection After Bites From Mosquitoes Infected With Two Novel P. Falciparum Strains
Role: collaborator
NCT01132209Not ApplicableCompleted
Suture Techniques to Reduce the Incidence of The inCisional Hernia
Role: collaborator
NCT01627951Not ApplicableCompleted
Comparison of Three Plasmodium Falciparum Isolates in a Controlled Human Malaria Infection
Role: collaborator
NCT00126958Unknown
Cost-Effectiveness in Bladder Cancer
Role: collaborator
All 6 trials loaded